Organizing pneumonia is a pathologic entity characterized by intra-alveolar buds of granulation tissue that can extend to the bronchiolar lumen. It is a non-specific finding reflecting a pattern of pulmonary response to aggression that can be cryptogenic or associated with several causes. Pulmonary actinomycosis is a rare infectious disease, of bacterial aetiology, and of difficult diagnosis. This disease usually causes non-specific respiratory symptoms and radiological findings, and the treatment is based on the use of antibiotics. The authors describe a clinical case of a 53-year-old male smoker (50 pack years), initially seen for complaints of right-sided chest pain and sub-febrile temperature. Imaging studies revealed a mass in the inferior right lobe and enlarged mediastinal lymph nodes. Empirical treatment with antibiotics caused partial and temporary improvement. Transthoracic biopsy revealed a pattern of organizing pneumonia with giant multinucleated cell granulomas. Repeat imaging studies revealed an enlargement of the pulmonary mass and therefore a right inferior lobectomy was performed. The pathologic study revealed a histological pattern of organizing pneumonia surrounding inflammatory bronchiectasis with a large number of Actinomyces colonies. To our knowledge there is presently no report in the literature of organizing pneumonia associated with Actinomyces infection.

1.
Cordier JF: Cryptogenic organising pneumonia. Eur Respir J 2006;28:422–446.
2.
Epler GR: Bronchiolitis obliterans organizing pneumonia. Arch Intern Med 2001;161:158–164.
3.
American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 2002;165:277–304.
4.
Tonelli AR, Lottenberg R, Allan RW, Sriram PS: Rituximab-induced hypersensitivity pneumonitis. Respiration 2009;78:225–229.
5.
Shi JH, Liu HR, Xu WB, Feng RE, Zhang ZH, Tian XL, Zhu YJ: Pulmonary manifestations of Sjogren’s syndrome. Respiration 2009;78:377–386.
6.
Oymak FS, Demirbas HM, Mavili E, Akgun H, Gulmez I, Demir R, Ozesmi M: Bronchiolitis obliterans organizing pneumonia: clinical and roentgenological features in 26 cases. Respiration 2005;72:254–262.
7.
Perez de Llano LA, Racamonde AV, Bande MJ, Piquer MO, Nieves FB, Feijoo AR: Bronchiolitis obliterans with organizing pneumonia associated with acute coxiella burnetii infection. Respiration 2001;68:425–427.
8.
Maldonado F, Daniels CE, Hoffman EA, Yi ES, Ryu JH: Focal organizing pneumonia on surgical lung biopsy: causes, clinicoradiologic features, and outcomes. Chest 2007;132:1579–1583.
9.
Oikonomou A, Hansell DM: Organizing pneumonia: the many morphological faces. Eur Radiol 2002;12:1486–1496.
10.
Schlesinger C, Koss MN: The organizing pneumonias: an update and review. Curr Opin Pulm Med 2005;11:422–430.
11.
Kapotsis GE, Daniil Z, Klimopoulos S, Malagari K, Roussos C, Rontogianni D, Papiris SA: A painful and swollen right breast in a young male. Eur Respir J 2004;24:1066–1068.
12.
Mabeza GF, Macfarlane J: Pulmonary actinomycosis. Eur Respir J 2003;21:545–551.
13.
Kim TS, Han J, Koh WJ, Choi JC, Chung MJ, Lee JH, Shim SS, Chong S: Thoracic actinomycosis: CT features with histopathologic correlation. AJR Am J Roentgenol 2006;186:225–231.
14.
Cheon JE, Im JG, Kim MY, Lee JS, Choi GM, Yeon KM: Thoracic actinomycosis: CT findings. Radiology 1998;209:229–233.
15.
Madhusudhan KS, Gamanagatti S, Seith A, Hari S: Pulmonary infections mimicking cancer: report of four cases. Singapore Med J 2007;48:e327–e331.
16.
de Montpreville VT, Nashashibi N, Dulmet EM: Actinomycosis and other bronchopulmonary infections with bacterial granules. Ann Diagn Pathol 1999;3:67–74.
17.
Yildiz O, Doganay M: Actinomycoses and nocardia pulmonary infections. Curr Opin Pulm Med 2006;12:228–234.
18.
Takayanagi N, Kagiyama N, Ishiguro T, Tokunaga D, Sugita Y: Etiology and outcome of community-acquired lung abscess. Respiration 2010;80:98–105.
19.
Brown JR: Human actinomycosis: a study of 181 subjects. Hum Pathol 1973;4:319–330.
20.
Glaser S, Schaper C, Obst A, Ittermann T, Volzke H, Felix SB, Vogelmeier C, Dorr M, Ewert R, Koch B: Impact of different definitions of airflow limitation on the prevalence of chronic obstructive pulmonary disease in the general population. Respiration 2010;80:292–300.
21.
Bradley B, Branley HM, Egan JJ, Greaves MS, Hansell DM, Harrison NK, Hirani N, Hubbard R, Lake F, Millar AB, Wallace WA, Wells AU, Whyte MK, Wilsher ML: Interstitial lung disease guideline: the British thoracic society in collaboration with the thoracic society of Australia and New Zealand and the Irish thoracic society. Thorax 2008;63(suppl 5):v1–v58.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.